Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Aug;35(8):1601–1604. doi: 10.1128/aac.35.8.1601

Role of intestinal excretion in the effect of subcutaneously administered sedecamycin on cecal infection caused by Treponema hyodysenteriae in mice.

T Hayashi 1, J Okada 1, S Kondo 1, T Yamazaki 1
PMCID: PMC245226  PMID: 1929332

Abstract

The therapeutic effects of subcutaneously administered sedecamycin on experimental Treponema hyodysenteriae infection in mice were evaluated. Sedecamycin was more active than tiamulin and lincomycin. The efficacy of sedecamycin upon subcutaneous administration was similar to that upon oral administration. Sedecamycin given subcutaneously provided similar degrees of protection in bile duct-ligated and intact mice. Pharmacokinetic studies utilizing a liquid chromatographic technique were carried out to determine the concentration of sedecamycin in the cecum, the site of T. hyodysenteriae infection in mice. Little sedecamycin was found; however, lankacidinol, a major metabolite of sedecamycin, was found in the cecal contents of intact mice after subcutaneous or oral administration of sedecamycin. Lankacidinol was also found in the cecal contents of bile duct-ligated mice, although the concentration found after subcutaneous administration of sedecamycin was much lower than that found after subcutaneous or oral administration to intact mice. These results indicate that sedecamycin is excreted directly into the intestinal tract as an active metabolite by a route other than the bile duct. It is suggested that this intestinal excretion plays an important role in the efficacy of subcutaneously administered sedecamycin against cecal infection of mice by T. hyodysenteriae.

Full text

PDF
1601

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blaha T., Erler W., Burch D. G. Swine dysentery control in the German Democratic Republic and the suitability of injections of tiamulin for the programme. Vet Rec. 1987 Oct 31;121(18):416–419. doi: 10.1136/vr.121.18.416. [DOI] [PubMed] [Google Scholar]
  2. Burch D. G., Heard T. W., Tasker J. B. Tiamulin injection for the treatment of swine dysentery. Vet Rec. 1983 Sep 10;113(11):236–237. doi: 10.1136/vr.113.11.236. [DOI] [PubMed] [Google Scholar]
  3. Dayton P. G., Israili Z. H., Henderson J. D. Elimination of drugs by passive diffusion from blood to intestinal lumen: factors influencing nonbiliary excretion by the intestinal tract. Drug Metab Rev. 1983;14(6):1193–1206. doi: 10.3109/03602538308991427. [DOI] [PubMed] [Google Scholar]
  4. Glock R. D., Harris D. L., Kluge J. P. Localization of spirochetes with the structural characteristics of Treponema hyodysenteriae in the lesions of swine dysentery. Infect Immun. 1974 Jan;9(1):167–178. doi: 10.1128/iai.9.1.167-178.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Haass A., Lüllmann H., Peters T. Absorption rates of some cardiac glycosides and portal blood flow. Eur J Pharmacol. 1972 Sep;19(3):366–370. doi: 10.1016/0014-2999(72)90103-3. [DOI] [PubMed] [Google Scholar]
  6. Hallén B., Räf L. Species differences in the intestinal excretion of emepronium. Pharmacol Toxicol. 1987 Oct;61(4):242–245. doi: 10.1111/j.1600-0773.1987.tb01811.x. [DOI] [PubMed] [Google Scholar]
  7. Hamdy A. H., Kratzer D. D. Therapeutic effects of parenteral administration of lincomycin on experimentally transmitted swine dysentery. Am J Vet Res. 1981 Feb;42(2):178–182. [PubMed] [Google Scholar]
  8. Harris D. L., Glock R. D., Christensen C. R., Kinyon J. M. Inoculation of pigs with Treponema hyodysenteriae (new species) and reproduction f the disease. Vet Med Small Anim Clin. 1972 Jan;67(1):61–64. [PubMed] [Google Scholar]
  9. Harris D. L., Kinyon J. M., Mullin M. T., Glock R. D. Isolation and propagation of spirochetes from the colon of swine dysentery affected pigs. Can J Comp Med. 1972 Jan;36(1):74–76. [PMC free article] [PubMed] [Google Scholar]
  10. Hayashi T., Suenaga I., Narukawa N., Yamazaki T. In vitro and in vivo activities of sedecamycin against Treponema hyodysenteriae. Antimicrob Agents Chemother. 1988 Apr;32(4):458–461. doi: 10.1128/aac.32.4.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Holland D. R., Quay J. F. Intestinal secretion of erythromycin base. J Pharm Sci. 1976 Mar;65(3):417–419. doi: 10.1002/jps.2600650325. [DOI] [PubMed] [Google Scholar]
  12. Israili Z. H., Dayton P. G. Enhancement of xenobiotic elimination: role of intestinal excretion. Drug Metab Rev. 1984;15(5-6):1123–1159. doi: 10.3109/03602538409033559. [DOI] [PubMed] [Google Scholar]
  13. Joens L. A., Glock R. D. Experimental infection in mice with Treponema hyodysenteriae. Infect Immun. 1979 Aug;25(2):757–760. doi: 10.1128/iai.25.2.757-760.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kennedy G. A., Strafuss A. C. Scanning electron microscopy of the lesions of swine dysentery. Am J Vet Res. 1976 Apr;37(4):395–401. [PubMed] [Google Scholar]
  15. Kennedy M. J., Rosnick D. K., Ulrich R. G., Yancey R. J., Jr Association of Treponema hyodysenteriae with porcine intestinal mucosa. J Gen Microbiol. 1988 Jun;134(6):1565–1576. doi: 10.1099/00221287-134-6-1565. [DOI] [PubMed] [Google Scholar]
  16. Okada J., Kondo S. Liquid chromatographic method for determining the macrolide antibiotic sedecamycin and its major metabolites in swine plasma and tissues. J Assoc Off Anal Chem. 1987 Sep-Oct;70(5):818–824. [PubMed] [Google Scholar]
  17. Olson L. D., Rodabaugh D. E. Clinical and pathologic features of various drug-related problems in the control of swine dysentery. J Am Vet Med Assoc. 1978 Oct 1;173(7):843–851. [PubMed] [Google Scholar]
  18. Songer J. G., Kinyon J. M., Harris D. L. Selective medium for isolation of Treponema hyodysenteriae. J Clin Microbiol. 1976 Jul;4(1):57–60. doi: 10.1128/jcm.4.1.57-60.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Struble C. B. In situ intestinal absorption of 2-chloro-N-isopropylacetanilide (propachlor) and non-biliary excretion of metabolites into the intestinal tract of rats, pigs and chickens. Xenobiotica. 1991 Jan;21(1):85–95. doi: 10.3109/00498259109039453. [DOI] [PubMed] [Google Scholar]
  20. Suenaga I., Yamazaki T. Experimental Treponema hyodysenteriae infection of mice. Zentralbl Bakteriol Mikrobiol Hyg A. 1984 Aug;257(3):348–356. [PubMed] [Google Scholar]
  21. Suenaga I., Yamazaki T. Experimental infection with Treponema hyodysenteriae in nude mice. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Jul;254(4):528–533. [PubMed] [Google Scholar]
  22. Taylor D. J., Alexander T. J. The production of dysentery in swine by feeding cultures containing a spirochaete. Br Vet J. 1971 Nov;127(11):58–61. doi: 10.1016/s0007-1935(17)37282-2. [DOI] [PubMed] [Google Scholar]
  23. Welsh M. J., Smith P. L., Fromm M., Frizzell R. A. Crypts are the site of intestinal fluid and electrolyte secretion. Science. 1982 Dec 17;218(4578):1219–1221. doi: 10.1126/science.6293054. [DOI] [PubMed] [Google Scholar]
  24. de Vries M. H., Rademaker C. M., Geerlings C., Van Dijk A., Noordhoek J. Pharmacokinetic modelling of the effect of activated charcoal on the intestinal secretion of theophylline, using the isolated vascularly perfused rat small intestine. J Pharm Pharmacol. 1989 Aug;41(8):528–533. doi: 10.1111/j.2042-7158.1989.tb06520.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES